×
About 1,677 results

ALLMedicine™ Insulin Pumps Center

Research & Reviews  667 results

Widening health inequalities related to Type 1 diabetes care in children and young peop...
https://doi.org/10.1111/dme.14620
Diabetic Medicine : a Journal of the British Diabetic Ass... Ng SM, Evans ML

Jun 10th, 2021 - In this recent 2019/20 audit, 96% (168/173) of paediatric diabetes teams submitted data and included a total of 29,242 children and young people (CYP) up to the age of 24 years, and Type 1 diabetes consisted of 27,653 CYP. One of the key findings ...

Diabetes: Device Therapy.
https://www.ncbi.nlm.nih.gov/pubmed/33970589
FP Essentials; Pasarica M

May 10th, 2021 - Insulin pumps, continuous glucose monitors (CGMs), and hybrid closed-loop insulin pumps with CGMs are available for the management of type 1 diabetes in patients of all ages and type 2 diabetes in patients treated with multiple daily injections of...

Position statement: The need for EU legislation to require disclosure and labelling of ...
https://doi.org/10.1111/jdv.17238
Journal of the European Academy of Dermatology and Venere... Herman A, Uter W et. al.

May 6th, 2021 - In recent years, skin reactions secondary to the use of medical devices (MD), such as allergic contact dermatitis have increasingly been observed (e.g. to continuous blood sugar monitoring systems, insulin pumps, wound dressings, medical gloves, e...

Racial disparities in treatment and outcomes of children with type 1 diabetes.
https://doi.org/10.1111/pedi.13139
Pediatric Diabetes; Lipman TH, Smith JA et. al.

Apr 19th, 2021 - The aim of this study was to assess racial disparities in treatments and outcomes between Non-Hispanic black (NHB), Hispanic and Non-Hispanic white (NHW) children with type 1 diabetes (T1D). We reviewed electronic health records of children (<18 y...

Longevity of the novel ConvaTec infusion set with Lantern technology.
https://doi.org/10.1111/dom.14395
Diabetes, Obesity & Metabolism; Lal RA, Hsu L et. al.

Apr 6th, 2021 - Current insulin infusion sets are approved for only 2-3 days. The novel ConvaTec infusion set with Lantern technology is designed to extend infusion set wear time. The goal of this pilot study was to evaluate the duration of wear for this set. Thi...

see more →

Guidelines  7 results

A Type 1 diabetes technology pathway: consensus statement for the use of technology in ...
https://doi.org/10.1111/dme.13933
Diabetic Medicine : a Journal of the British Diabetic Ass... Choudhary P, Campbell F et. al.

Feb 18th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

Diabetes Technology: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S71

Dec 17th, 2018 - Diabetes technology is the term used to describe the hardware, devices, and software that people with diabetes use to help manage blood glucose levels, stave off diabetes complications, reduce the burden of living with diabetes, and improve qualit...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY...
https://doi.org/10.4158/PS-2017-0155
Endocrine Practice : Official Journal of the American Col... Grunberger G, Handelsman Y et. al.

Mar 16th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

JDRF Statement: Animas Exits the Insulin Pump Business - Guideline
http://www.jdrf.org/blog/2017/10/05/jdrf-statement-animas-exits-the-insulin-pump-business/
Juvenile Diabetes Research Foundation International

Oct 4th, 2017 - The choice of a pump should be made by people with diabetes and their doctors, and JDRF does not endorse products. For those Animas customers needing a new pump, the following links might be helpful.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  809 results

Widening health inequalities related to Type 1 diabetes care in children and young peop...
https://doi.org/10.1111/dme.14620
Diabetic Medicine : a Journal of the British Diabetic Ass... Ng SM, Evans ML

Jun 10th, 2021 - In this recent 2019/20 audit, 96% (168/173) of paediatric diabetes teams submitted data and included a total of 29,242 children and young people (CYP) up to the age of 24 years, and Type 1 diabetes consisted of 27,653 CYP. One of the key findings ...

'A Better Picture': First AACE Guidelines on Diabetes Technology
https://www.medscape.com/viewarticle/952127

May 30th, 2021 - The American Association of Clinical Endocrinology (AACE) has issued its first-ever official guidelines addressing the use of advanced technologies in the management of people with diabetes. The guidelines cover use of continuous glucose monitorin...

Diabetes: Device Therapy.
https://www.ncbi.nlm.nih.gov/pubmed/33970589
FP Essentials; Pasarica M

May 10th, 2021 - Insulin pumps, continuous glucose monitors (CGMs), and hybrid closed-loop insulin pumps with CGMs are available for the management of type 1 diabetes in patients of all ages and type 2 diabetes in patients treated with multiple daily injections of...

Position statement: The need for EU legislation to require disclosure and labelling of ...
https://doi.org/10.1111/jdv.17238
Journal of the European Academy of Dermatology and Venere... Herman A, Uter W et. al.

May 6th, 2021 - In recent years, skin reactions secondary to the use of medical devices (MD), such as allergic contact dermatitis have increasingly been observed (e.g. to continuous blood sugar monitoring systems, insulin pumps, wound dressings, medical gloves, e...

Racial disparities in treatment and outcomes of children with type 1 diabetes.
https://doi.org/10.1111/pedi.13139
Pediatric Diabetes; Lipman TH, Smith JA et. al.

Apr 19th, 2021 - The aim of this study was to assess racial disparities in treatments and outcomes between Non-Hispanic black (NHB), Hispanic and Non-Hispanic white (NHW) children with type 1 diabetes (T1D). We reviewed electronic health records of children (<18 y...

see more →

News  193 results

'A Better Picture': First AACE Guidelines on Diabetes Technology
https://www.medscape.com/viewarticle/952127

May 30th, 2021 - The American Association of Clinical Endocrinology (AACE) has issued its first-ever official guidelines addressing the use of advanced technologies in the management of people with diabetes. The guidelines cover use of continuous glucose monitorin...

Pumps and Patches: Technology Benefits Youth With Type 1 Diabetes
https://www.medscape.com/viewarticle/947742

Mar 18th, 2021 - An increase in the use of insulin pumps and continuous glucose monitoring (CGM) around the world is benefiting children with type 1 diabetes, new research finds. An analysis of data for more than 25,000 participants aged 18 years or younger with t...

Insulin Pumps Used Less in Black Children, Even With Insurance
https://www.staging.medscape.com/viewarticle/937167

Sep 9th, 2020 - Black children with type 1 diabetes in the United States are far less likely than white children to be prescribed insulin pumps, even among those with private health insurance, new research suggests. The data were published online September 1 in t...

Insulin Pumps Used Less in Black Children, Even With Insurance
https://www.medscape.com/viewarticle/937167

Sep 9th, 2020 - Black children with type 1 diabetes in the United States are far less likely than white children to be prescribed insulin pumps, even among those with private health insurance, new research suggests. The data were published online September 1 in t...

In Medicare, Insulin Costs More for Patients Who Use Pumps
https://www.medscape.com/viewarticle/936734

Sep 1st, 2020 - Under the US Medicare system, the cost of insulin is about 50% higher for beneficiaries who use insulin pumps than those who inject insulin, a new analysis reveals.   The issue was outlined, along with a "call to action", in a commentary recently ...

see more →